Efficacy and Safety of Bevacizumab in Active Brain Metastases from Non-Small Cell Lung Cancer

BACKGROUND: Bevacizumab is effective for the treatment of non-small cell lung cancer (NSCLC). Ongoing trials are exploring the safety of bevacizumab in patients with inactive, previously treated brain metastases. However, bevacizumab safety and efficacy in the treatment of active brain metastases is...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: De Braganca, Kevin C., Janjigian, Yelena Y., Azzoli, Christopher G., Kris, Mark G., Pietanza, Maria C., Nolan, Craig P., Omuro, Antonio M., Holodny, Andrei I., Lassman, Andrew B.
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3246379/
https://ncbi.nlm.nih.gov/pubmed/20440540
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-010-0200-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados